Birdwatch Archive

Birdwatch Note Rating

2023-12-12 06:47:03 UTC - HELPFUL

Rated by Participant: E734333C0169B1B4CFE5305532F646707E48ABC8E6AB1A0B9D997ACBB1F65975
Participant Details

Original Note:

The approval is based on positive clinical data from several ARCT-154 studies, including an ongoing 16,000 subject efficacy study performed in Vietnam as well as a Phase 3 COVID-19 booster trial. https://biomelbourne.org/japans-ministry-of-health-labour-and-welfare-approves-csl-and-arcturus-therapeutics-arct-154-the-first-self-amplifying-mrna-vaccine-approved-for-covid-in-adults/

All Note Details

Original Tweet

All Information

  • noteId - 1734393629538722131
  • participantId -
  • raterParticipantId - E734333C0169B1B4CFE5305532F646707E48ABC8E6AB1A0B9D997ACBB1F65975
  • createdAtMillis - 1702363623648
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 1
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1734393629538722131E734333C0169B1B4CFE5305532F646707E48ABC8E6AB1A0B9D997ACBB1F65975